Literature DB >> 8834586

Peritoneal mesothelioma: treatment approach based on natural history.

A M Averbach1, P H Sugarbaker.   

Abstract

A more modern treatment strategy for diffuse malignant peritoneal mesothelioma may be suggested (figure 3). Clinical suspicion of diffuse malignant mesothelioma (peritoneal carcinomatosis) calls for laparoscopy with evaluation of parietal and visceral peritoneum and multiple biopsies sufficient for definitive histologic diagnosis. Cytologic examination of ascitic fluid is not likely to be of benefit. CT of chest, abdomen, and pelvis is needed for evaluation of visceral involvement and the presence of distant metastases. Contrast enhancement of the gastrointestinal and urinary tract is necessary with the CT. Additional radiologic techniques for detection of distant metastases should be used if there are clinical or laboratory signs of extraperitoneal spread. After histologic diagnosis and extent of tumor spread have been documented, and if no symptoms of intestinal obstruction are present, the patient may be subjected to two to three courses of induction intraperitoneal chemotherapy. This will provide the clinician with important information on tumor response to chemotherapy, minimize tumor accumulation on bowel surfaces, and provide time for surgical conditioning. The time devoted to induction chemotherapy will allow occult distant metastases to be detected. In patients with a response or stable disease, cytoreductive surgery is attempted approximately 2 months after completion of induction chemotherapy. Surgery must be aimed at achieving complete or near-complete cytoreduction through the use of peritonectomy procedures [46,47]. Additional intraperitoneal chemotherapy should be administered intraoperatively and in the early postoperative period (figure 3). This treatment strategy may be the most feasible one according to existing knowledge of the natural history of diffuse malignant peritoneal mesothelioma. Only further phase II clinical trials can reveal the extent to which it is beneficial. Because of the rare occurrence of this disease, the quickest answer would come as a result of cooperative study by several groups experienced in these treatment modalities.

Entities:  

Mesh:

Year:  1996        PMID: 8834586     DOI: 10.1007/978-1-4613-1245-1_17

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  9 in total

Review 1.  Statement on malignant mesothelioma in the United Kingdom.

Authors: 
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Update on the management of malignant peritoneal mesothelioma.

Authors:  Paul H Sugarbaker
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 3.  Malignant peritoneal mesothelioma.

Authors:  B W Loggie
Journal:  Curr Treat Options Oncol       Date:  2001-10

4.  Effects of sex hormones on survival of peritoneal mesothelioma.

Authors:  Yeqian Huang; Nayef A Alzahrani; Winston Liauw; David L Morris
Journal:  World J Surg Oncol       Date:  2015-06-26       Impact factor: 2.754

5.  Incidence, Survival Analysis and Future Perspective of Primary Peritoneal Mesothelioma (PPM): A Population-Based Study from SEER Database.

Authors:  Asad Ullah; Abdul Waheed; Jaffar Khan; Ankita Mishra; Bisma Tareen; Noor Nama; Nabin Raj Karki; Muhammad Saleem Panezai; Luis Velasquez Zarate; Joseph White; Frederick D Cason; Nathaniel Matolo; Subhasis Misra; Nagla Abdel Karim
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

6.  Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma.

Authors:  Lana Bijelic; O Anthony Stuart; Paul Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-08-08       Impact factor: 2.260

Review 7.  Intracavitary therapies for mesothelioma.

Authors:  C F Verschraegen
Journal:  Curr Treat Options Oncol       Date:  2001-10

Review 8.  Peritoneal mesothelioma.

Authors:  Faheez Mohamed; Paul H Sugarbaker
Journal:  Curr Treat Options Oncol       Date:  2002-10

9.  Asbestos-induced peritoneal mesothelioma in a construction worker.

Authors:  Rodolfo Fonte; Salvatore Gambettino; Mario Melazzini; Mario Scelsi; Claudio Zanon; Stefano M Candura
Journal:  Environ Health Perspect       Date:  2004-04       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.